Hillman Solutions (HLMN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2025 Annual Meeting will be held virtually on June 3, 2025, with shareholders able to vote and ask questions online.
Key business items include electing three directors, advisory approval of executive compensation, increasing share reserves for equity and stock purchase plans, and ratifying the independent auditor.
Shareholders of record as of April 8, 2025, are eligible to vote, with multiple voting methods available including online, phone, mail, and during the meeting.
Voting matters and shareholder proposals
Proposals include electing three directors for terms expiring in 2026, a non-binding vote on executive compensation, increasing shares under the 2021 Equity Incentive Plan and Employee Stock Purchase Plan, and ratifying Deloitte & Touche LLP as auditor.
Board recommends voting FOR all proposals.
Approval standards and effects of abstentions and broker non-votes are detailed for each proposal.
Board of directors and corporate governance
Board consists of ten members, with a plan to declassify by 2027 so all directors are elected annually.
Three director nominees for 2026: Jon Michael Adinolfi, Douglas J. Cahill, and Diane Honda, all with significant industry and leadership experience.
Board committees: Audit, Compensation, and Nominating & ESG, all composed of independent directors.
Board leadership structure separates Chairman and CEO roles; Daniel O'Leary serves as Lead Independent Director.
Board diversity and qualifications are emphasized, with a broad range of skills and backgrounds represented.
Corporate Governance Principles, Code of Conduct, and policies on insider trading, hedging, and equity grants are in place.
Latest events from Hillman Solutions
- Five-year plan targets $2.5B sales by 2030 with 8–12% CAGR and strong margin expansion.HLMN
Investor Day 202620 Mar 2026 - Record Q3 sales and EBITDA growth led to raised guidance and improved leverage metrics.HLMN
Q3 202517 Mar 2026 - Record 2025 sales and EBITDA, with 2026 guidance focused on growth and margin normalization.HLMN
Q4 202517 Feb 2026 - Q2 net income and EBITDA rose on flat sales; profit outlook up, sales guidance down.HLMN
Q2 20242 Feb 2026 - Net income and EBITDA rose in Q3 2024, with higher guidance and a $7.8M True Value charge.HLMN
Q3 202416 Jan 2026 - Q1 sales and EBITDA grew, guidance held, but free cash flow pulled due to tariff risks.HLMN
Q1 202527 Dec 2025 - Record EBITDA, margin gains, and improved profitability set stage for 2025 growth.HLMN
Q4 202423 Dec 2025 - Q2 sales up 6.2%, guidance raised, tariffs raise costs, $100M buyback approved.HLMN
Q2 202523 Nov 2025